Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin - Concepedia

Concepedia

Publication | Closed Access

Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin

116

Citations

24

References

2005

Year

Sergio Anastasi, Gianluca Sala, Huiping Chen, Elisabetta Caprini, Giandomenico Russo, Stefano Iacovelli, Fabiana Lucini, Sigurður Ingvarsson, Oreste Segatto

Breast OncologyErbb-2 Oncogenic PotencyMedicineErbb2-amplified Breast CarcinomasImmunologyBreast CancerCancer BiologyCell BiologyRalt/mig-6 ExpressionTumor Biology

References

	Year	Citations

Page 1

Page 1